ホーム > 市場調査レポート > 医薬品

治験

市場調査レポート

商品コード

1397467

浮腫の臨床試験市場- 成長、将来展望、競合分析、2023年～2031年

Edema Clinical Trials Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

出版日: 2023年12月13日 | 発行: Acute Market Reports

| ページ情報: 英文 112 Pages | 納期: 即日から翌営業日

価格

PDF (Single User License)

USD 4,500 705,150円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 6,500 1,018,550円

レポートPDFを10名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 9,000 1,410,300円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.70円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

浮腫の臨床試験市場は大きな進化を遂げており、調査手法の進化と多様な参入企業層への注目の高まりにより、2023年から2031年の予測期間中にCAGR 5.5％で成長すると予測されます。多額の収益が計上された2022年から2023年から2031年の予測期間へと移行する中、浮腫の臨床試験市場は継続的な拡大が見込まれています。臨床試験で採用され続けている革新的な戦略は、浮腫治療の展望を形成し、多様な患者集団の複雑性に対処し、より効果的で患者中心の介入への道を開くことが期待されます。

治療アプローチの進歩

浮腫の臨床試験市場の最大の促進要因は、治療アプローチの絶え間ない進化です。新規薬剤候補や介入の出現が示すように、現在進行中の臨床試験では、浮腫により効果的に対処するための革新的なメカニズムが模索されています。血管透過性やリンパ機能のような特定の経路を標的とした研究的治療法は、初期段階の試験で有望な結果を示しています。これらの進歩は、治療効果を高め、副作用を軽減するための協調的な努力を反映しており、より的を絞った個別化された治療への道を開くものです。

小児科研究の重視の高まり

浮腫の臨床試験の状況を形成する重要な原動力は、小児科の研究が重視されるようになったことです。小児集団におけるユニークな課題と明確な生理学的反応を認識し、最近の臨床試験は、特に小児に合わせたエビデンスに基づく介入の開発に重点を置いています。この変化は、多相試験に小児コホートを組み入れ、この層に対する浮腫治療の安全性と有効性を確保していることからも明らかです。小児患者のアンメットメディカルニーズに対応することで、これらの試験は多様な年齢層にわたる浮腫管理のより包括的な理解に貢献しています。

高まるデジタル技術の統合

浮腫の臨床試験市場を促進するもう一つの主要因は、デジタル技術の統合が進んでいることです。電子データ収集システムから浮腫関連パラメータをモニタリングするウェアラブルデバイスまで、臨床試験はデータの正確性を高め、患者のモニタリングを合理化し、試験全体の効率を向上させるためにデジタル技術の革新を活用しています。リアルタイムのデータ収集と分析により、研究者は情報に基づいた意思決定を行うことができ、臨床試験のペースが加速し、効果的な浮腫治療法のタイムリーな開発に貢献します。

患者の募集と維持における課題

浮腫の臨床試験市場における大きな抑制要因は、患者の確保と維持という根強い課題です。治療アプローチやデジタル技術の進歩にもかかわらず、多様で代表的な参加者を登録することは依然として複雑な課題です。この制約を裏付ける証拠として、十分な数の適格な参加者を確保することが困難なため、試験期間が長引いたり、コストが増大したりする事例があります。さらに、いくつかの試験で観察された高い離脱率は、試験期間を通じて患者の参加と維持を強化する革新的な戦略の必要性を強調しています。

フェーズ別第III相試験が市場を独占

2022年の浮腫の臨床試験市場は、フェーズIII試験が最も高い収益を上げるなど、さまざまなフェーズで大きな収益を上げています。しかし、第IV相試験は2023年から2031年の予測期間中に最も高いCAGRを示しました。これは、市販後調査へのシフトと長期的な治療結果の継続的な探求を示しています。このダイナミックなセグメンテーションは、浮腫の臨床研究が進化していることを強調するものであり、先進段階と市販後調査の両方に重点を置いています。

参加者別：成人セグメントが市場を独占

2022年の市場参入企業別セグメンテーションでは、成人からの収益が堅調であることが示され、臨床試験におけるこの層への重点的な取り組みを反映しています。しかし、予測期間中にCAGRが最も高かったのは小児科であり、若年層の浮腫への対応における小児科研究の重要性が認識されつつあることを浮き彫りにしています。同時に、老年医学は、臨床試験デザインにおいて高齢患者特有の特性を考慮する包括的なアプローチを示し、大きな収益を維持しました。

北米は世界のリーダーであり続ける

2022年の浮腫の臨床試験市場は地理的に多様な動向を示し、北米が収益をリードしました。しかし、臨床試験活動の急増と研究インフラへの投資の増加を反映して、アジア太平洋地域が最も高いCAGRを示しました。収益とCAGRのバランスを考慮すると、こうした地理的動向は浮腫の臨床試験の世界性を強調するものであり、さまざまな地域が研究の進歩に独自に貢献しています。

市場競争は予測期間中に激化へ

競合情勢では、ファイザー、ノバルティス、ジョンソン・エンド・ジョンソン、大塚ホールディングス、F.ホフマン・ラ・ロシュ、バイエル、ジェネンテック、バイオジェン、Inflammasome Therapeutics、サノフィ、OcuTerra Therapeuticsなどの主要企業が技術革新を推進し、浮腫の臨床試験の将来を形成しています。これらの主要企業は、2022年に多額の収益を計上し、2023年から2031年まで継続的な成長を見込んでいます。先進的な治療アプローチの開発、小児科研究の重視、デジタル技術の活用に戦略的に重点を置く彼らは、浮腫の臨床試験の展望において影響力のある存在として位置づけられています。市場が発展するにつれて、これらのプレーヤーは臨床研究の進展において極めて重要な役割を果たし、最終的には浮腫のより効果的な治療法の開発に貢献すると予想されます。

イントロダクション
世界の浮腫の臨床試験市場金額 2021-2031
市場力学
- 市場促進要因
- 市場抑制要因
- 主な課題
- 主な機会
促進要因と抑制要因の影響分析
シーソー分析
ポーターのファイブフォースモデル
- サプライヤーパワー
- バイヤーパワー
- 代替品の脅威
- 新規参入業者の脅威
- 競争企業間の敵対関係
PESTEL分析
- 政治的情勢
- 経済情勢
- テクノロジーの情勢
- 法的情勢
- 社会的情勢

第5章浮腫の臨床試験市場：フェーズ別 2021-2031

市場概要
成長・収益分析：2022 vs 2031
市場セグメンテーション
- フェーズI
- フェーズ II
- フェーズⅢ
- フェーズ IV

第6章浮腫の臨床試験市場：参加者別 2021-2031

市場概要
成長・収益分析：2022 vs 2031
市場セグメンテーション
- 小児科
- 大人
- 老人医学

第7章浮腫の臨床試験市場：研究デザイン別 2021-2031

市場概要
成長・収益分析：2022 vs 2031
市場セグメンテーション
- 介入試験
- 観察試験
- 拡張アクセストライアル

第8章浮腫の臨床試験市場：タイプ別 2021-2031

市場概要
成長・収益分析：2022 vs 2031
市場セグメンテーション
- 全身性浮腫
- 局所的な浮腫

第9章北米の浮腫の臨床試験市場 2021-2031

市場概要
浮腫の臨床試験市場：フェーズ別 2021-2031
浮腫の臨床試験市場：参加者別 2021-2031
浮腫の臨床試験市場：研究デザイン別 2021-2031
浮腫の臨床試験市場：タイプ別 2021-2031
浮腫の臨床試験市場：地域別 2021-2031
- 北米
  - 米国
  - カナダ
  - その他北米地域

第10章英国と欧州連合の浮腫の臨床試験市場 2021-2031

市場概要
浮腫の臨床試験市場：フェーズ別 2021-2031
浮腫の臨床試験市場：参加者別 2021-2031
浮腫の臨床試験市場：研究デザイン別 2021-2031
浮腫の臨床試験市場：タイプ別 2021-2031
浮腫の臨床試験市場：地域別 2021-2031
- 英国と欧州連合
  - 英国
  - ドイツ
  - スペイン
  - イタリア
  - フランス
  - その他欧州地域

第11章アジア太平洋の浮腫の臨床試験市場 2021-2031

市場概要
浮腫の臨床試験市場：フェーズ別 2021-2031
浮腫の臨床試験市場：参加者別 2021-2031
浮腫の臨床試験市場：研究デザイン別 2021-2031
浮腫の臨床試験市場：タイプ別 2021-2031
浮腫の臨床試験市場：地域別 2021-2031
- アジア太平洋
  - 中国
  - 日本
  - インド
  - オーストラリア
  - 韓国
  - その他アジア太平洋地域

第12章ラテンアメリカの浮腫の臨床試験市場 2021-2031

市場概要
浮腫の臨床試験市場：フェーズ別 2021-2031
浮腫の臨床試験市場：参加者別 2021-2031
浮腫の臨床試験市場：研究デザイン別 2021-2031
浮腫の臨床試験市場：タイプ別 2021-2031
浮腫の臨床試験市場：地域別 2021-2031
- ラテンアメリカ
  - ブラジル
  - メキシコ
  - その他ラテンアメリカ地域

第13章中東・アフリカの浮腫の臨床試験市場 2021-2031

市場概要
浮腫の臨床試験市場：フェーズ別 2021-2031
浮腫の臨床試験市場：参加者別 2021-2031
浮腫の臨床試験市場：研究デザイン別 2021-2031
浮腫の臨床試験市場：タイプ別 2021-2031
浮腫の臨床試験市場：地域別 2021-2031
- 中東・アフリカ
  - GCC
  - アフリカ
  - その他中東・アフリカ地域

第14章企業プロファイル

Pfizer Inc.
Novartis AG
Johnson & Johnson
Otsuka Holdings
F. Hoffmann-La Roche Ltd.
Bayer
Genentech Inc
Biogen
Inflammasome Therapeutics
Sanofi S.A.
OcuTerra Therapeutics
その他の主要企業

図表

List of Tables

TABLE 1 Global Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 2 Global Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 3 Global Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 4 Global Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 5 North America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 6 North America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 7 North America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 8 North America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 9 U.S. Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 10 U.S. Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 11 U.S. Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 12 U.S. Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 13 Canada Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 14 Canada Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 15 Canada Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 16 Canada Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 17 Rest of North America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 18 Rest of North America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 19 Rest of North America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 20 Rest of North America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 21 UK and European Union Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 22 UK and European Union Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 23 UK and European Union Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 24 UK and European Union Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 25 UK Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 26 UK Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 27 UK Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 28 UK Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 29 Germany Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 30 Germany Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 31 Germany Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 32 Germany Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 33 Spain Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 34 Spain Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 35 Spain Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 36 Spain Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 37 Italy Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 38 Italy Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 39 Italy Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 40 Italy Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 41 France Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 42 France Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 43 France Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 44 France Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 45 Rest of Europe Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 46 Rest of Europe Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 47 Rest of Europe Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 48 Rest of Europe Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 49 Asia Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 50 Asia Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 51 Asia Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 52 Asia Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 53 China Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 54 China Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 55 China Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 56 China Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 57 Japan Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 58 Japan Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 59 Japan Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 60 Japan Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 61 India Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 62 India Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 63 India Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 64 India Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 65 Australia Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 66 Australia Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 67 Australia Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 68 Australia Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 69 South Korea Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 70 South Korea Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 71 South Korea Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 72 South Korea Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 73 Latin America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 74 Latin America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 75 Latin America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 76 Latin America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 77 Brazil Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 78 Brazil Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 79 Brazil Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 80 Brazil Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 81 Mexico Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 82 Mexico Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 83 Mexico Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 84 Mexico Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 85 Rest of Latin America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 86 Rest of Latin America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 87 Rest of Latin America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 88 Rest of Latin America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 89 Middle East and Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 90 Middle East and Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 91 Middle East and Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 92 Middle East and Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 93 GCC Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 94 GCC Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 95 GCC Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 96 GCC Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 97 Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 98 Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 99 Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 100 Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
TABLE 101 Rest of Middle East and Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
TABLE 102 Rest of Middle East and Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
TABLE 103 Rest of Middle East and Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
TABLE 104 Rest of Middle East and Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)

List of Figures

FIG. 1 Global Edema Clinical Trials Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Edema Clinical Trials Market: Quality Assurance
FIG. 5 Global Edema Clinical Trials Market, By Phase, 2022
FIG. 6 Global Edema Clinical Trials Market, By Participant, 2022
FIG. 7 Global Edema Clinical Trials Market, By Study Design, 2022
FIG. 8 Global Edema Clinical Trials Market, By Type, 2022
FIG. 9 Global Edema Clinical Trials Market, By Geography, 2022
FIG. 10 Market Geographical Opportunity Matrix - Global Edema Clinical Trials Market, 2022

FIG. 11Market Positioning of Key Edema Clinical Trials Market Players, 2022

FIG. 12Global Edema Clinical Trials Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

FIG. 13 Global Edema Clinical Trials Market, By Phase, 2022 Vs 2031, %
FIG. 14 Global Edema Clinical Trials Market, By Participant, 2022 Vs 2031, %
FIG. 15 Global Edema Clinical Trials Market, By Study Design, 2022 Vs 2031, %
FIG. 16 Global Edema Clinical Trials Market, By Type, 2022 Vs 2031, %
FIG. 17 U.S. Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 18 Canada Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 19 Rest of North America Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 20 UK Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 21 Germany Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 22 Spain Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 23 Italy Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 24 France Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 25 Rest of Europe Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 26 China Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 27 Japan Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 28 India Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 29 Australia Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 30 South Korea Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 31 Rest of Asia Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 32 Brazil Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 33 Mexico Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 34 Rest of Latin America Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 35 GCC Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 36 Africa Edema Clinical Trials Market (US$ Million), 2021 - 2031
FIG. 37 Rest of Middle East and Africa Edema Clinical Trials Market (US$ Million), 2021 - 2031

Product Code: 140025-12-23

The edema clinical trials market is undergoing significant advancements and is expected to grow at a CAGR of 5.5% during the forecast period of 2023 to 2031, fueled by evolving research methodologies and a growing focus on diverse participant demographics. As we transition from 2022, marked by substantial revenues, to the forecast period of 2023 to 2031, the Edema Clinical Trials market is poised for continued expansion. The ongoing innovative strategies employed in clinical trials are expected to shape the landscape of edema treatment, addressing the complexities of diverse patient populations and paving the way for more effective and patient-centric interventions.

Advancements in Therapeutic Approaches

The foremost driver in the Edema Clinical Trials market is the continuous evolution of therapeutic approaches. As evidenced by the emergence of novel drug candidates and interventions, ongoing clinical trials are exploring innovative mechanisms to address edema more effectively. Investigational treatments targeting specific pathways, such as vascular permeability and lymphatic function, have demonstrated promising results in early-phase trials. These advancements reflect a concerted effort to enhance treatment efficacy and reduce adverse effects, paving the way for more targeted and personalized interventions.

Increased Emphasis on Pediatric Research

A crucial driver shaping the landscape of edema clinical trials is the increased emphasis on pediatric research. Recognizing the unique challenges and distinct physiological responses in pediatric populations, recent trials have focused on developing evidence-based interventions specifically tailored to children. This shift is evident in the inclusion of pediatric cohorts in multi-phase trials, ensuring the safety and efficacy of edema treatments for this demographic. By addressing the unmet medical needs of pediatric patients, these trials contribute to a more comprehensive understanding of edema management across diverse age groups.

Growing Integration of Digital Technologies

Another key driver propelling the Edema Clinical Trials market is the growing integration of digital technologies. From electronic data capture systems to wearable devices monitoring edema-related parameters, clinical trials are leveraging digital innovations to enhance data accuracy, streamline patient monitoring, and improve overall trial efficiency. Real-time data collection and analysis enable researchers to make informed decisions, accelerating the pace of clinical trials and contributing to the timely development of effective edema treatments.

Challenges in Patient Recruitment and Retention

A significant restraint in the Edema Clinical Trials market is the persistent challenge of patient recruitment and retention. Despite the advancements in therapeutic approaches and digital technologies, enrolling a diverse and representative participant pool remains a complex task. Evidence supporting this restraint includes instances of prolonged trial timelines and increased costs due to difficulties in recruiting a sufficient number of eligible participants. Additionally, the high attrition rates observed in some trials underscore the need for innovative strategies to enhance patient engagement and retention throughout the trial duration.

By Phase: Phase III trials Dominates the Market

In 2022, the Edema Clinical Trials market experienced substantial revenue across different phases, with Phase III trials generating the highest revenue. However, Phase IV trials demonstrated the highest CAGR during the forecast period from 2023 to 2031, indicating a shift towards post-marketing research and continued exploration of long-term treatment outcomes. This dynamic segmentation underscores the evolving nature of clinical research in edema, emphasizing both advanced stages and post-marketing surveillance.

By Participant: The Adults Segment Dominates the Market

Market segmentation by participants in 2022 showcased robust revenue streams from adults, reflecting the predominant focus on this demographic in clinical trials. However, Pediatrics demonstrated the highest CAGR during the forecast period, highlighting a growing recognition of the importance of pediatric research in addressing edema in younger populations. Simultaneously, Geriatrics maintained substantial revenue, illustrating a comprehensive approach that considers the unique characteristics of elderly patients in clinical trial design.

North America Remains the Global Leader

Geographically, the Edema Clinical Trials market exhibited diverse trends in 2022, with North America leading in revenue generation. However, the Asia-Pacific region showcased the highest CAGR, reflecting a surge in clinical trial activities and increasing investment in research infrastructure. Balancing revenue and CAGR, these geographic trends underscore the global nature of edema clinical trials, with diverse regions contributing uniquely to research advancements.

Market Competition to Intensify during the Forecast Period

In the competitive landscape, top players such as Pfizer Inc., Novartis AG, Johnson & Johnson, Otsuka Holdings, F. Hoffmann-La Roche Ltd., Bayer, Genentech, Inc, Biogen, Inflammasome Therapeutics, Sanofi S.A. and OcuTerra Therapeutics are driving innovation and shaping the future of edema clinical trials. These key players reported substantial revenues in 2022, expecting continued growth from 2023 to 2031. Their strategic focus on developing advanced therapeutic approaches, emphasizing pediatric research, and leveraging digital technologies positions them as influential entities in the edema clinical trials landscape. As the market evolves, these players are anticipated to play a pivotal role in advancing clinical research, ultimately contributing to the development of more effective treatments for edema.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofEdema Clinical Trials market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Edema Clinical Trials market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Phase

Phase I

Phase II

Phase III

Phase IV

Participant

Pediatrics

Adults

Geriatrics

Study Design

Interventional Trials

Observational Trials

Expanded Access Trials

Type

Systemic Edema

Localized Edema

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Edema Clinical Trials market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Edema Clinical Trials market?

Which is the largest regional market for Edema Clinical Trials market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Edema Clinical Trials market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Edema Clinical Trials market worldwide?

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Edema Clinical Trials Market
2.2. Global Edema Clinical Trials Market, By Phase, 2022 (US$ Million)
2.3. Global Edema Clinical Trials Market, By Participant, 2022 (US$ Million)
2.4. Global Edema Clinical Trials Market, By Study Design, 2022 (US$ Million)
2.5. Global Edema Clinical Trials Market, By Type, 2022 (US$ Million)
2.6. Global Edema Clinical Trials Market, By Geography, 2022 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2022

3. Edema Clinical Trials Market: Competitive Analysis

3.1. Market Positioning of Key Edema Clinical Trials Market Vendors
3.2. Strategies Adopted by Edema Clinical Trials Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031

4. Edema Clinical Trials Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Edema Clinical Trials Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape

5. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
- 5.3.1. Phase I
- 5.3.2. Phase II
- 5.3.3. Phase III
- 5.3.4. Phase IV

6. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
- 6.3.1. Pediatrics
- 6.3.2. Adults
- 6.3.3. Geriatrics

7. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
- 7.3.1. Interventional Trials
- 7.3.2. Observational Trials
- 7.3.3. Expanded Access Trials

8. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
- 8.3.1. Systemic Edema
- 8.3.2. Localized Edema

9. North America Edema Clinical Trials Market, 2021-2031, USD (Million)

9.1. Market Overview
9.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
9.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
9.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
9.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
9.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
- 9.6.1.North America
  - 9.6.1.1. U.S.
    - 9.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 9.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 9.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 9.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 9.6.1.2. Canada
    - 9.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 9.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 9.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 9.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 9.6.1.3. Rest of North America
    - 9.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 9.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 9.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 9.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

10. UK and European Union Edema Clinical Trials Market, 2021-2031, USD (Million)

10.1. Market Overview
10.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
10.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
10.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
10.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
10.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
- 10.6.1.UK and European Union
  - 10.6.1.1. UK
    - 10.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 10.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 10.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 10.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 10.6.1.2. Germany
    - 10.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 10.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 10.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 10.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 10.6.1.3. Spain
    - 10.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 10.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 10.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 10.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 10.6.1.4. Italy
    - 10.6.1.4.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 10.6.1.4.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 10.6.1.4.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 10.6.1.4.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 10.6.1.5. France
    - 10.6.1.5.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 10.6.1.5.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 10.6.1.5.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 10.6.1.5.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 10.6.1.6. Rest of Europe
    - 10.6.1.6.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 10.6.1.6.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 10.6.1.6.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 10.6.1.6.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

11. Asia Pacific Edema Clinical Trials Market, 2021-2031, USD (Million)

11.1. Market Overview
11.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
11.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
11.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
11.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
11.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
- 11.6.1.Asia Pacific
  - 11.6.1.1. China
    - 11.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 11.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 11.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 11.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 11.6.1.2. Japan
    - 11.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 11.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 11.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 11.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 11.6.1.3. India
    - 11.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 11.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 11.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 11.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 11.6.1.4. Australia
    - 11.6.1.4.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 11.6.1.4.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 11.6.1.4.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 11.6.1.4.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 11.6.1.5. South Korea
    - 11.6.1.5.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 11.6.1.5.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 11.6.1.5.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 11.6.1.5.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 11.6.1.6. Rest of Asia Pacific
    - 11.6.1.6.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 11.6.1.6.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 11.6.1.6.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 11.6.1.6.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

12. Latin America Edema Clinical Trials Market, 2021-2031, USD (Million)

12.1. Market Overview
12.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
12.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
12.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
12.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
12.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
- 12.6.1.Latin America
  - 12.6.1.1. Brazil
    - 12.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 12.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 12.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 12.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 12.6.1.2. Mexico
    - 12.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 12.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 12.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 12.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 12.6.1.3. Rest of Latin America
    - 12.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 12.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 12.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 12.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

13. Middle East and Africa Edema Clinical Trials Market, 2021-2031, USD (Million)

13.1. Market Overview
13.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
13.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
13.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
13.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
13.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
- 13.6.1.Middle East and Africa
  - 13.6.1.1. GCC
    - 13.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 13.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 13.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 13.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 13.6.1.2. Africa
    - 13.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 13.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 13.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 13.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  - 13.6.1.3. Rest of Middle East and Africa
    - 13.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
    - 13.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
    - 13.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
    - 13.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

14. Company Profile

14.1. Pfizer Inc.
- 14.1.1. Company Overview
- 14.1.2. Financial Performance
- 14.1.3. Product Portfolio
- 14.1.4. Strategic Initiatives
14.2. Novartis AG
- 14.2.1. Company Overview
- 14.2.2. Financial Performance
- 14.2.3. Product Portfolio
- 14.2.4. Strategic Initiatives
14.3. Johnson & Johnson
- 14.3.1. Company Overview
- 14.3.2. Financial Performance
- 14.3.3. Product Portfolio
- 14.3.4. Strategic Initiatives
14.4. Otsuka Holdings
- 14.4.1. Company Overview
- 14.4.2. Financial Performance
- 14.4.3. Product Portfolio
- 14.4.4. Strategic Initiatives
14.5. F. Hoffmann-La Roche Ltd.
- 14.5.1. Company Overview
- 14.5.2. Financial Performance
- 14.5.3. Product Portfolio
- 14.5.4. Strategic Initiatives
14.6. Bayer
- 14.6.1. Company Overview
- 14.6.2. Financial Performance
- 14.6.3. Product Portfolio
- 14.6.4. Strategic Initiatives
14.7. Genentech, Inc
- 14.7.1. Company Overview
- 14.7.2. Financial Performance
- 14.7.3. Product Portfolio
- 14.7.4. Strategic Initiatives
14.8. Biogen
- 14.8.1. Company Overview
- 14.8.2. Financial Performance
- 14.8.3. Product Portfolio
- 14.8.4. Strategic Initiatives
14.9. Inflammasome Therapeutics
- 14.9.1. Company Overview
- 14.9.2. Financial Performance
- 14.9.3. Product Portfolio
- 14.9.4. Strategic Initiatives
14.10. Sanofi S.A.
- 14.10.1. Company Overview
- 14.10.2. Financial Performance
- 14.10.3. Product Portfolio
- 14.10.4. Strategic Initiatives
14.11. OcuTerra Therapeutics
- 14.11.1. Company Overview
- 14.11.2. Financial Performance
- 14.11.3. Product Portfolio
- 14.11.4. Strategic Initiatives
14.12. Other Notable Players
- 14.12.1. Company Overview
- 14.12.2. Financial Performance
- 14.12.3. Product Portfolio
- 14.12.4. Strategic Initiatives

ライセンス / 価格

PDF (Single User License)

USD 4,500 705,150円

PDF (Multi User License)

USD 6,500 1,018,550円

PDF (Enterprise License)

USD 9,000 1,410,300円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.70円

お電話でのお問い合わせ

044-952-0102

( 土日・祝日を除く )

浮腫

浮腫の臨床試験市場- 成長、将来展望、競合分析、2023年～2031年

Edema Clinical Trials Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

治療アプローチの進歩

小児科研究の重視の高まり

高まるデジタル技術の統合

患者の募集と維持における課題

フェーズ別第III相試験が市場を独占

参加者別：成人セグメントが市場を独占

北米は世界のリーダーであり続ける

市場競争は予測期間中に激化へ

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 浮腫の臨床試験市場：競合分析

第4章 浮腫の臨床試験市場：マクロ分析と市場力学

第5章 浮腫の臨床試験市場：フェーズ別 2021-2031

第6章 浮腫の臨床試験市場：参加者別 2021-2031

第7章 浮腫の臨床試験市場：研究デザイン別 2021-2031

第8章 浮腫の臨床試験市場：タイプ別 2021-2031

第9章 北米の浮腫の臨床試験市場 2021-2031

第10章 英国と欧州連合の浮腫の臨床試験市場 2021-2031

第11章 アジア太平洋の浮腫の臨床試験市場 2021-2031

第12章 ラテンアメリカの浮腫の臨床試験市場 2021-2031

第13章 中東・アフリカの浮腫の臨床試験市場 2021-2031

第14章 企業プロファイル